Studying a diabetes drug to improve recovery after stroke surgery
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests whether a medication commonly used for diabetes can help patients who had a stroke due to a blocked large artery in the brain. The drug is given as an injection after the standard procedure to remove the blood clot, and researchers will see if it leads to better recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old.
- You had a stroke caused by a blockage in a large artery in the front part of your brain, and you had a procedure called endovascular thrombectomy (EVT) to remove the clot.
- Your stroke symptoms are moderate to severe, as measured by a standard score (NIHSS) of 6 or higher.
- Before the stroke, you were able to live independently without any help (score of 0 or 1 on the modified Rankin Scale).
- The study drug can be given within 6 hours after your EVT procedure.
- You are not pregnant or planning to become pregnant, and you don't have certain medical conditions listed in the study rules.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a diabetes drug called a DPP4 inhibitor can help protect memory and thinking after a mild stroke. It is for people with type 2 diabetes who have had a stroke within the last two weeks.
This study tests whether a medication called a GLP-1 receptor agonist (a type of drug used for diabetes) can improve recovery after a major stroke that was treated with a procedure to remove the blood clot. The goal is to see if this drug helps reduce further brain damage and improve outcomes.
This trial tests whether a medicine called a GLP-1 receptor agonist (similar to diabetes drugs) can improve recovery after a specific type of bleeding stroke. The study aims to see if this drug can reduce brain swelling and help patients regain function.
This trial tests whether a drug called semaglutide (usually used for diabetes) can improve brain recovery when given after a stroke clot removal procedure. You may receive the drug or a placebo, and researchers will check your neurological outcomes.
This Phase 2 study tests whether a semaglutide injection given under the skin soon after an acute ischemic stroke can improve recovery. It may help reduce disability, especially if treatment starts within about 4.5 hours of symptom onset.
This trial tests whether semaglutide changes blood flow in the brain and the brain’s “barrier” (how well the brain is protected) in people with type 2 diabetes. It may help researchers understand brain-related effects of diabetes treatment using scans and blood tests.
Hear when a new Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.